Safety and efficiency of using Omaulizumab in bronchial asthma-Reference-Cited by-同舟云学术

Safety and efficiency of using Omaulizumab in bronchial asthma

Published:2019-09-02 Issue:2 Volume:10 Page:6-12
ISSN:2618-7876
Container-title:Medical Herald of the South of Russia
language:
Short-container-title:Med. vestn. Ûga Ross.

Author:

Strel’tsov E. A.¹^ORCID,Demidov V. S.¹^ORCID,Tsoy L. V.¹^ORCID,Korovina M. E.¹^ORCID,Razyschikova N. M.¹^ORCID,Karzhauova А. E.¹^ORCID

Affiliation:

1. Karaganda Medical University

Publisher

Rostov State Medical University

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference44 articles.

1. Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev. 2017;278(1):162-172. doi: 10.1111/imr.12557

2. Nabih ES, Kamel HF, Kamel TB. Association between CD14 polymorphism (-1145G/A) and childhood bronchial asthma. Biochem Genet. 2016;54:50-60. doi: 10.1007/s10528-015-9699-4

3. Dissanayake S, Jain M, Grothe B, Mciver T, Papi A. An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthma. Pulm Pharmacol Ther. 2015;35:19-27. doi: 10.1016/j.pupt.2015.10.001

4. Crocker DD , Kinyota S, Dumitru GG, Ligon CB, Herman EJ, Ferdinands JM et all. Effectiveness of home-based, multitrigger, multicomponent interventions with an environmental focus for reducing asthmamorbidity: a community guide systematic review. Am J Prev Med. 2011;41(2 Suppl 1):S5-32. doi: 10.1016/j.amepre.2011.05.012

5. CDC. Asthma: most recent asthma data. 2017. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/asthma/most_recent_data.htm

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of omalizumab in children;Glavvrač (Chief Medical Officer);2023-07-27

2. Safety of omalizumab in the treatment of moderate-to-severe bronchial asthma;Medical Journal of the Russian Federation;2022-07-26